Ligature-induced periodontitis in mice potentially accelerates CD4+ T-cell senescence and exacerbates rheumatoid arthritis - Top-Institutions - MDSpire

Ligature-induced periodontitis in mice potentially accelerates CD4+ T-cell senescence and exacerbates rheumatoid arthritis

  • By

  • Jinfeng Li

  • Terukazu Sanui

  • Miyu Shida

  • Karen Yotsumoto

  • Mwannes Ahmad

  • Ziyu Wang

  • Meng Xiao

  • Chikako Hayashi

  • Takanori Shinjo

  • Takaharu Taketomi

  • Takao Fukuda

  • Fusanori Nishimura

  • May 26, 2026

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Kyushu University
    Kyushu University

    Fukuoka, Fukuoka

    Key Differentiators

    • Periodontology

  • #2

    Landesuntersuchungsamt Rheinland-Pfalz
    Landesuntersuchungsamt Rheinland-Pfalz

    Mainz, Rheinland-Pfalz

    Key Differentiators

    • Veterinary Medicine

  • #3

    Charles River
    Charles River

    Sulzfeld, Baden-Württemberg

    Key Differentiators

    • Laboratory Services

  • #4

    Southern Medical University
    Southern Medical University

    Guangzhou, Guangdong

    Key Differentiators

    • Medical Education

  • #5

    University of Calgary
    University of Calgary

    Calgary, Alberta

    Key Differentiators

    • Veterinary Medicine

Original Source(s)

Ligature-induced periodontitis in mice potentially accelerates CD4+ T-cell senescence and exacerbates rheumatoid arthritis

  • by Jinfeng Li, Terukazu Sanui, Miyu Shida, Karen Yotsumoto, Mwannes Ahmad, Ziyu Wang, Meng Xiao, Chikako Hayashi, Takanori Shinjo, Takaharu Taketomi, Takao Fukuda, Fusanori Nishimura

  • May 26, 2026

Related Content

AAO Updates HCQ Retinopathy Guidance

Updated recommendations emphasize dosing limits and screening for toxicity risk.

Impact of Polysaccharides from Traditional Chinese Medicine on Rheumatoid Arthritis via Gut Microbiota Alteration: A Systematic Review of Animal Studies

JAK Monotherapy Shows Efficacy in RA Review

A systematic review found Janus kinase inhibitor monotherapy improved outcomes vs methotrexate or placebo, but direct comparisons with combination therapy were limited.